NCT06589414

Brief Summary

This is a prospective, multicentric, regional study designed to assess the feasibility of setting up a summary consultation with a general practitioner (GP) to complement the consultation for the announcement of a cancer diagnosis. 171 patients will be included in the study. Each patient will be followed for 6 months.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
171

participants targeted

Target at P75+ for not_applicable

Timeline
8mo left

Started Jan 2025

Typical duration for not_applicable

Geographic Reach
1 country

5 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress67%
Jan 2025Jan 2027

First Submitted

Initial submission to the registry

September 3, 2024

Completed
16 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

January 8, 2025

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Last Updated

February 10, 2026

Status Verified

February 1, 2026

Enrollment Period

1.7 years

First QC Date

September 3, 2024

Last Update Submit

February 9, 2026

Conditions

Solid Tumours

Keywords

Solid TumoursAnnouncement systemGeneral practitioner

Outcome Measures

Primary Outcomes (1)

  • The ratio between the number of patients who attended the summary consultation with the general practitioner within 15 days of being diagnosed with cancer in the referral care centre and the total number of patients included in the study.

    21 months after the start of the study

Secondary Outcomes (10)

  • The reasons why the summary consultation with the GP did not take place within 15 days of the consultation to announce the cancer diagnosis.

    21 months after the start of the study

  • The type of consultations carried out with the GP (physical consultations, teleconsultations or home visits) will be presented as follows, using standard descriptive statistics.

    21 months after the start of the study

  • The number of cancellations of consultations with GPs will be presented as follows, using standard descriptive statistics.

    21 months after the start of the study

  • The number of postponed consultations with the GP will be presented as follows, using standard descriptive statistics.

    21 months after the start of the study

  • The overall compliance will be presented as follows, using standard descriptive statistics.

    21 months after the start of the study

  • +5 more secondary outcomes

Study Arms (1)

DAMeGe protocol

OTHER
Other: Patient care according to the DAMeGe protocol (organisation of a summary consultation with the GP)

Interventions

Patient care according to the DAMeGe protocol (organisation of a summary consultation with the GP)OTHER

A summary consultation with the patient's general practitioner (GP) will take place within 15 days of the consultation to announce the cancer diagnosis. This patient-general practitioner consultation will complement the initial consultation. At the end of the summary consultation, the patient's satisfaction and that of the GP will be assessed using satisfaction questionnaires. In addition, patients will be asked to complete a "patient diary" for the duration of their participation in the study (6 months), in order to record the dates of consultations with the GP and the dates of consultations and/or hospitalisations at the referral care centre.

DAMeGe protocol

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years.
  • Patient with a solid tumour whatever the organ.
  • Patient treated in one of the participating centres as part of a system for announcing the diagnosis of a solid cancer.
  • Patient undergoing cancer treatment in one of the participating centres.
  • Patient with a registered general practitioner in the Occitanie region.
  • Patient affiliated to a French Social Security scheme.

You may not qualify if:

  • Patient already included in another clinical trial concerning a care pathway.
  • Patient deprived of liberty or under legal protection (curatorship and guardianship, safeguard of justice).
  • Pregnant or breast-feeding woman.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

CH Auch

Auch, France

Location

CH Carcassonne

Carcassonne, 11000, France

Location

CHU Larrey

Toulouse, France

Location

CHU Rangueil

Toulouse, France

Location

Institut Universitaire du Cancer de Toulouse - Oncopole

Toulouse, France

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 3, 2024

First Posted

September 19, 2024

Study Start

January 8, 2025

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

January 1, 2027

Last Updated

February 10, 2026

Record last verified: 2026-02

Locations

FR(5)